Nanotechnology Now

Our NanoNews Digest Sponsors

Heifer International

Wikipedia Affiliate Button

Home > Press > Arrowhead Announces Option Grant to CEO under NASDAQ Marketplace Rule 4350

Abstract:
Arrowhead Research Corporation (Nasdaq: ARWR) announced today that in accordance with NASDAQ Marketplace Rule 4350(i)(1)(A)(iv), the Compensation Committee of the Board of Directors approved an inducement grant of a stock option to Christopher Anzalone, Arrowhead's new President and Chief Executive Officer. On December 3, 2007, Dr. Anzalone was granted an option to purchase 2,000,000 shares of the common stock of Arrowhead at an exercise price of $3.92, the closing price of Arrowhead's shares on that date. The option will vest with respect to 1/8 of the shares on the six month anniversary of his date of hire, June 1, 2008, with the balance vesting in 42 equal monthly installments. The option was granted outside Arrowhead's equity incentive plans and as a material inducement to Dr. Anzalone's employment with the company.

Arrowhead Announces Option Grant to CEO under NASDAQ Marketplace Rule 4350

PASADENA, CA | Posted on January 26th, 2008

The grant was previously disclosed in a Current Report on Form 8-K filed with the Securities and Exchange Commission on December 4, 2007. This release is being issued to comply with NASDAQ Marketplace Rule 4350(i)(1)(A)(iv).

####

About Arrowhead Research Corporation
Arrowhead Research Corporation (www.arrowheadresearch.com) (NASDAQ:ARWR) is a leading nanotechnology company commercializing new technologies in the areas of life sciences, electronics and energy. Arrowhead is building value for shareholders through the progress of majority owned subsidiaries founded on nanotechnologies originally developed at universities. The company works closely with universities to source early stage deals and to generate rights to intellectual property covering promising new nanotechnologies. Currently, Arrowhead has five subsidiaries commercializing nanotech products and applications, including anti-cancer drugs, RNAi therapeutics, fullerene anti-oxidants, carbon-based electronics and compound semiconductor materials.

Safe Harbor Statement under the Private Securities Litigation Reform Act of 1995:

This news release contains forward-looking statements within the meaning of the "safe harbor" provisions of the Private Securities Litigation Reform Act of 1995. These statements are based upon our current expectations and speak only as of the date hereof. Our actual results may differ materially and adversely from those expressed in any forward-looking statements as a result of various factors and uncertainties, including the future success of our clinical studies, our ability to successfully develop and manufacture products, rapid technological change in our industry, changes in demand for our future products, legislative, regulatory and competitive developments and general economic conditions. Our Annual Report on Form 10-K, and other SEC filings discuss these and other important risk factors that may affect our business, results of operations and financial condition. We undertake no obligation to revise or update publicly any forward-looking statements for any reason.

For more information, please click here

Contacts:
Arrowhead Research
Virginia Dadey
Vice President
Investor Relations
212-541-3707

Copyright © Business Wire 2008

If you have a comment, please Contact us.

Issuers of news releases, not 7th Wave, Inc. or Nanotechnology Now, are solely responsible for the accuracy of the content.

Bookmark:
Delicious Digg Newsvine Google Yahoo Reddit Magnoliacom Furl Facebook

Related News Press

News and information

Nano-kirigami: 'Paper-cut' provides model for 3D intelligent nanofabrication July 13th, 2018

UMBC researchers develop nanoparticles to reduce internal bleeding caused by blast trauma July 13th, 2018

Leti and Oscaro Partner on Letiís New Low-Power, Low-Cost Transceiver to Track Parcels July 12th, 2018

Oxford Instrumentsí 22 Tesla superconducting magnet system commissioned at the UAM, making it the most intense magnetic field available outside a large international facility July 12th, 2018

Investments/IPO's/Splits

Nanometrics to Participate in the 10th Annual CEO Investor Summit 2018: Accredited investor and publishing research analyst event held concurrently with SEMICON West and Intersolar 2018 in San Francisco June 28th, 2018

180 Degree Capital Corp. to Provide Live Remote Access to Its Annual Meeting of Shareholders on June 12, 2018 June 12th, 2018

Nanometrics Updates Time of Webcast at Stifel 2018 Cross Sector Insight Conference June 12th, 2018

Arrowhead Pharmaceuticals to Present at Upcoming June 2018 Conferences May 31st, 2018

Announcements

Nano-kirigami: 'Paper-cut' provides model for 3D intelligent nanofabrication July 13th, 2018

UMBC researchers develop nanoparticles to reduce internal bleeding caused by blast trauma July 13th, 2018

Barium ruthenate: A high-yield, easy-to-handle perovskite catalyst for the oxidation of sulfides July 13th, 2018

Leti and Oscaro Partner on Letiís New Low-Power, Low-Cost Transceiver to Track Parcels July 12th, 2018

NanoNews-Digest
The latest news from around the world, FREE



  Premium Products
NanoNews-Custom
Only the news you want to read!
 Learn More
NanoStrategies
Full-service, expert consulting
 Learn More











ASP
Nanotechnology Now Featured Books




NNN

The Hunger Project